(VIANEWS) – CVR Partners, LP (UAN), CrossAmerica Partners LP (CAPL), Eli Lilly and Company (LLY) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. CVR Partners, LP (UAN)
145.75% Payout Ratio
CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea and ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is headquartered in Sugar Land, Texas.
Earnings Per Share
As for profitability, CVR Partners, LP has a trailing twelve months EPS of $22.47.
PE Ratio
CVR Partners, LP has a trailing twelve months price to earnings ratio of 3.48. Meaning, the purchaser of the share is investing $3.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.34%.
2. CrossAmerica Partners LP (CAPL)
143.84% Payout Ratio
CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, operation of convenience stores, and ownership and leasing of real estate used in the retail distribution of motor fuels in the United States. The company operates in two segments, Wholesale and Retail. The Wholesale segment engages in the wholesale distribution of motor fuels to lessee dealers, independent dealers, commission agents, and company operated retail sites. The Retail segment is involved in the sale of convenience merchandise items; and retail sale of motor fuels at company operated retail sites and retail sites operated by commission agents. As of March 1, 2021, the company distributed fuel to approximately 1,700 locations; and owned or leased approximately 1,100 sites. CrossAmerica GP LLC operates as the general partner of the company. The company was formerly known as Lehigh Gas Partners LP and changed its name to CrossAmerica Partners LP in October 2014. CrossAmerica Partners LP was founded in 1992 and is based in Allentown, Pennsylvania.
Earnings Per Share
As for profitability, CrossAmerica Partners LP has a trailing twelve months EPS of $1.46.
PE Ratio
CrossAmerica Partners LP has a trailing twelve months price to earnings ratio of 13.48. Meaning, the purchaser of the share is investing $13.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 91.94%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CrossAmerica Partners LP’s EBITDA is 0.37.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 2, 2023, the estimated forward annual dividend rate is 2.1 and the estimated forward annual dividend yield is 10.76%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 71.8% and a negative 65.1%, respectively.
Volume
Today’s last reported volume for CrossAmerica Partners LP is 30218 which is 6.69% below its average volume of 32385.
3. Eli Lilly and Company (LLY)
58.77% Payout Ratio
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $7.17.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 81.55. Meaning, the purchaser of the share is investing $81.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 65.6%.
Yearly Top and Bottom Value
Eli Lilly and Company’s stock is valued at $584.69 at 02:23 EST, above its 52-week high of $559.21.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 13, 2023, the estimated forward annual dividend rate is 4.52 and the estimated forward annual dividend yield is 0.81%.
4. Northrim BanCorp (NRIM)
43.48% Payout Ratio
Northrim BanCorp, Inc. operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates in two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement accounts, money market deposit accounts, and certificates of deposit. It also provides family residential mortgages; commercial loans, such as secured and unsecured loans for working capital and expansion; commercial real estate loans; construction loans for commercial real estate projects, and land development and residential subdivision construction loans; and loans for automobiles, recreational vehicles, boats, and other consumer purchases, as well as home equity and commercial credit lines, and factoring services. In addition, the company offers other services that include consumer online banking, mobile app and mobile deposit, mobile Web and text banking, business online banking, personal finance, online documents, consumer and business debit cards, home equity advantage access cards, and telebanking and automated teller services. Further, it provides personalized checks, overdraft protection from savings accounts, commercial drive-up banking, automatic transfers and payments, people pay, external and wire transfers, bill pay, direct payroll deposits, electronic tax payments, automated clearing house origination and receipt, remote deposit capture, and account reconciliation and positive pay services, as well as merchant and cash management programs, annuity products, and long term investment portfolios. As of December 31, 2020, the company operated 16 branches in Anchorage, the Matanuska-Susitna Valley, Juneau, Fairbanks, Ketchikan, Sitka, and Kenai Peninsula. Northrim BanCorp, Inc. was founded in 1990 and is headquartered in Anchorage, Alaska.
Earnings Per Share
As for profitability, Northrim BanCorp has a trailing twelve months EPS of $5.06.
PE Ratio
Northrim BanCorp has a trailing twelve months price to earnings ratio of 8.44. Meaning, the purchaser of the share is investing $8.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.34%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 6, 2023, the estimated forward annual dividend rate is 2.4 and the estimated forward annual dividend yield is 5.53%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 29% and a negative 27%, respectively.
Sales Growth
Northrim BanCorp’s sales growth is negative 3.1% for the current quarter and negative 6.5% for the next.
5. CB Financial Services (CBFV)
33.56% Payout Ratio
CB Financial Services, Inc. operates as the bank holding company for Community Bank that provides various banking products and services for individuals and businesses in southwestern Pennsylvania, West Virginia, and Ohio. The company's primary deposit products include demand deposits, NOW accounts, money market accounts, and savings accounts, as well as time deposit products. Its loan products comprise residential real estate loans, such as one- to four-family mortgage loans, home equity installment loans, and home equity lines of credit; commercial real estate loans that are secured primarily by improved properties, such as retail facilities, office buildings, and other non-residential buildings; construction loans to individuals to finance the construction of residential dwellings, as well as for the construction of commercial properties, including hotels, apartment buildings, housing developments, and owner-occupied properties used for businesses; commercial and industrial loans, and lines of credit; consumer loans consisting of indirect auto loans, secured and unsecured loans, and lines of credit; and other loans. In addition, the company conducts insurance agency activities by offering property and casualty, commercial liability, surety, and other insurance products. It operates through its main office and 13 branch offices in Greene, Allegheny, Washington, Fayette, and Westmoreland counties in southwestern Pennsylvania; Marshall and Ohio counties in West Virginia; and Belmont County in Ohio, as well as one loan production offices in Allegheny County. The company was founded in 1901 and is headquartered in Carmichaels, Pennsylvania.
Earnings Per Share
As for profitability, CB Financial Services has a trailing twelve months EPS of $2.92.
PE Ratio
CB Financial Services has a trailing twelve months price to earnings ratio of 7.36. Meaning, the purchaser of the share is investing $7.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.02%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 52.9%, now sitting on 55.21M for the twelve trailing months.
Volume
Today’s last reported volume for CB Financial Services is 4011 which is 42.44% below its average volume of 6969.
Sales Growth
CB Financial Services’s sales growth is negative 3.4% for the ongoing quarter and negative 5.1% for the next.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Sales Growth
1’s sales growth is 1% for the present quarter and 1% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
